ecancermedicalscience

ecancermedicalscience is an open access cancer journal focused on under-resourced communities. In order to help reduce global inequalities in cancer care and treatment, we provide free access to all articles from the point of publication and we only charge authors who have specific funding to cover publication costs.

The journal considers articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, controlled trials (in particular if they are independent or publicly funded trials), health systems, cancer policy and regulatory aspects of cancer care.

Editor-in-Chief: Dr Enrique Soto Pérez de Celis MD, PhD, FASCO

ISSN: 1754-6605

Submit article

1566-metastatic-breast-cancer-in-kenya-survival-prognosis-and-management-at-a-tertiary-referral-centre

Research: Metastatic breast cancer in Kenya: survival, prognosis and management at a tertiary referral centre

Mwongeli Matheka, Miriam Mutebi, Shahin Sayed, Asim Jamal Shaikh

27 Jun 2023

https://doi.org/10.3332/ecancer.2023.1566

Abstract | Full Article | PDF

1549-neoadjuvant-chemotherapy-in-a-rare-type-of-very-locally-advanced-sinonasal-carcinomas-long-term-results-from-a-tertiary-care-centre

Clinical Study: Neoadjuvant chemotherapy in a rare type of very locally advanced sinonasal carcinomas – long-term results from a tertiary care centre

Saswata Saha, Vijay M Patil, Vanita Noronha, Nandini Menon, Ajay Kumar Singh, Mannavi Suman, Amit Agrawal, Satvik Khaddar, Shatabdi Chakraborty, Prathamesh S Pai, Devendra A Chaukar, Pankaj Chaturvedi, Sarbani Ghosh Laskar, Kumar Prabhash

11 May 2023

https://doi.org/10.3332/ecancer.2023.1549

Abstract | Full Article | PDF

1539-outcome-and-prognostic-variables-in-childhood-rhabdomyosarcoma-rms-with-emphasis-on-impact-of-foxo1-fusions-in-non-metastatic-rms-experience-from-a-tertiary-cancer-centre-in-india

Research: Outcome and prognostic variables in childhood rhabdomyosarcoma (RMS) with emphasis on impact of FOXO1 Fusions in non-metastatic RMS: Experience from a tertiary cancer centre in India

Subramaniam Ramanathan, Sneha Sisodiya, Omshree Shetty, Maya Prasad, Badira C Parambil, Sneha Shah, Mukta Ramadwar, Nehal Khanna, Siddhartha Laskar, Sajid Qureshi, Tushar Vora, Girish Chinnaswamy

27 Apr 2023

https://doi.org/10.3332/ecancer.2023.1539

Abstract | Full Article | PDF

1537-evaluation-of-side-effects-and-compliance-to-chemotherapy-in-breast-cancer-patients-at-a-nigerian-tertiary-hospital

Research: Evaluation of side effects and compliance to chemotherapy in breast cancer patients at a Nigerian tertiary hospital

Sharif Adeniyi Folorunso, Oyindamola Olajumoke Abiodun, Abbas Adesina Abdus-salam, Funmilola Olanike Wuraola

21 Apr 2023

https://doi.org/10.3332/ecancer.2023.1537

Abstract | Full Article | PDF

1535-durable-effect-of-imatinib-and-metronomic-chemotherapy-with-capecitabine-in-pancreatic-carcinoma

Case Report: Durable effect of imatinib and metronomic chemotherapy with capecitabine in pancreatic carcinoma

Sana Al-Sukhun, Karim Khalidi

21 Apr 2023

https://doi.org/10.3332/ecancer.2023.1535

Abstract | Full Article | PDF

1523-metastatic-pheochromocytoma-and-paraganglioma-a-retrospective-multicentre-analysis-on-prognostic-and-predictive-factors-to-chemotherapy

Research: Metastatic pheochromocytoma and paraganglioma: a retrospective multicentre analysis on prognostic and predictive factors to chemotherapy

Samara T Pacheco, Mauro D Donadio, Felipe Almeida, Juan M O'Connor, Valeria De Miguel, Mariano Dioca, Jose Huaman, Arinilda C Bragagnoli, Rui F Weschenfelder, Paola M Beltran, Rachel P Riechelmann

20 Mar 2023

https://doi.org/10.3332/ecancer.2023.1523

Abstract | Full Article | PDF